Taiwan-based MLOps startup InfuseAI raises $4.3M Series A led by Wistron Corporation
23 Apr, 2021
– Ossium Health is a therapeutics company that leverages stem cell science to improve treatment for patients with blood and immune diseases.
– The company raised $63m in Series B funding.
– The round was co-led by General Catalyst and Vivo Capital with participation from previous investors First Round Capital, Manta Ray Ventures, and XYZ Capital.
– The new investment will be used to develop stem cell therapies for patients with life-threatening blood and immune diseases.